391 related articles for article (PubMed ID: 32157196)
1. Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response.
Scher JU; Nayak RR; Ubeda C; Turnbaugh PJ; Abramson SB
Nat Rev Rheumatol; 2020 May; 16(5):282-292. PubMed ID: 32157196
[TBL] [Abstract][Full Text] [Related]
2. The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New-Onset Rheumatoid Arthritis.
Artacho A; Isaac S; Nayak R; Flor-Duro A; Alexander M; Koo I; Manasson J; Smith PB; Rosenthal P; Homsi Y; Gulko P; Pons J; Puchades-Carrasco L; Izmirly P; Patterson A; Abramson SB; Pineda-Lucena A; Turnbaugh PJ; Ubeda C; Scher JU
Arthritis Rheumatol; 2021 Jun; 73(6):931-942. PubMed ID: 33314800
[TBL] [Abstract][Full Text] [Related]
3. Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response.
Yan H; Su R; Xue H; Gao C; Li X; Wang C
Front Immunol; 2021; 12():789334. PubMed ID: 34975886
[TBL] [Abstract][Full Text] [Related]
4. The evidence for microbiome manipulation in inflammatory arthritis.
Jethwa H; Abraham S
Rheumatology (Oxford); 2017 Sep; 56(9):1452-1460. PubMed ID: 27789760
[TBL] [Abstract][Full Text] [Related]
5. The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review.
Peretti S; Torracchi S; Russo E; Bonomi F; Fiorentini E; Aoufy KE; Bruni C; Lepri G; Orlandi M; Chimenti MS; Guiducci S; Amedei A; Matucci-Cerinic M; Bellando Randone S
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672830
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota and inflammatory joint diseases.
Breban M
Joint Bone Spine; 2016 Dec; 83(6):645-649. PubMed ID: 27238190
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate pharmacogenetics in rheumatoid arthritis.
Brinker RR; Ranganathan P
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S33-9. PubMed ID: 21044431
[TBL] [Abstract][Full Text] [Related]
8. Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors.
Bodio C; Grossi C; Pregnolato F; Favalli EG; Biggioggero M; Marchesoni A; Murgo A; Filippini M; Migliorini P; Caporali R; Pellerito R; Ciccia F; Sarzi-Puttini P; Perosa F; Paolazzi G; Hollan I; Bendtzen K; Meroni PL; Borghi MO
Autoimmun Rev; 2020 May; 19(5):102509. PubMed ID: 32173513
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17 Inhibition in Spondyloarthritis Is Associated With Subclinical Gut Microbiome Perturbations and a Distinctive Interleukin-25-Driven Intestinal Inflammation.
Manasson J; Wallach DS; Guggino G; Stapylton M; Badri MH; Solomon G; Reddy SM; Coras R; Aksenov AA; Jones DR; Girija PV; Neimann AL; Heguy A; Segal LN; Dorrestein PC; Bonneau R; Guma M; Ciccia F; Ubeda C; Clemente JC; Scher JU
Arthritis Rheumatol; 2020 Apr; 72(4):645-657. PubMed ID: 31729183
[TBL] [Abstract][Full Text] [Related]
10. Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Biggioggero M; Benucci M; Li Gobbi F; Grossi V; Infantino M; Meacci F; Manfredi M; Guiducci S; Bellando-Randone S; Matucci-Cerinic M; Foti R; Di Gangi M; Mosca M; Tani C; Palmieri F; Goletti D;
Semin Arthritis Rheum; 2016 Apr; 45(5):519-32. PubMed ID: 26607440
[TBL] [Abstract][Full Text] [Related]
11. The Future of Axial Spondyloathritis Treatment.
Maguire S; Sengupta R; O'Shea F
Rheum Dis Clin North Am; 2020 May; 46(2):357-365. PubMed ID: 32340707
[TBL] [Abstract][Full Text] [Related]
12. Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review.
Martín-López M; Carmona L; Balsa A; Calvo-Alén J; Sanmartí R; Tornero J; Rosas J
Rheumatol Int; 2018 Jun; 38(6):975-983. PubMed ID: 29616303
[TBL] [Abstract][Full Text] [Related]
13. Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point towards a paradigm shift.
Chatzidionysiou K; Sfikakis PP
RMD Open; 2019; 5(2):e000993. PubMed ID: 31413870
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors.
Muszbek N; Proudfoot C; Fournier M; Chen CI; Kuznik A; Kiss Z; Gal P; Michaud K
J Manag Care Spec Pharm; 2019 Nov; 25(11):1268-1280. PubMed ID: 31663465
[TBL] [Abstract][Full Text] [Related]
15. Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication.
Dalén J; Svedbom A; Hernlund E; Olofsson T; Black CM
Adv Ther; 2023 Oct; 40(10):4657-4674. PubMed ID: 37599341
[TBL] [Abstract][Full Text] [Related]
16. Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
Fan J; Jiang T; He D
Front Immunol; 2023; 14():1189036. PubMed ID: 37841256
[TBL] [Abstract][Full Text] [Related]
17. Precision Medicine in Rheumatoid Arthritis.
Bluett J; Barton A
Rheum Dis Clin North Am; 2017 Aug; 43(3):377-387. PubMed ID: 28711140
[TBL] [Abstract][Full Text] [Related]
18. Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?
Ranganathan P; Eisen S; Yokoyama WM; McLeod HL
Ann Rheum Dis; 2003 Jan; 62(1):4-9. PubMed ID: 12480661
[TBL] [Abstract][Full Text] [Related]
19. Differential Effects of Inflammation on Bone and Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis.
Stavre Z; Upchurch K; Kay J; Gravallese EM
Curr Rheumatol Rep; 2016 Dec; 18(12):72. PubMed ID: 27812955
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Gut Microbiota in Rheumatoid Arthritis Patients: Disease-Related Dysbiosis and Modifications Induced by Etanercept.
Picchianti-Diamanti A; Panebianco C; Salemi S; Sorgi ML; Di Rosa R; Tropea A; Sgrulletti M; Salerno G; Terracciano F; D'Amelio R; Laganà B; Pazienza V
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
